
Video of a T-cell attacking a cancer cell.
February 15, 2017 (YouTube)
Video of a T-cell attacking a cancer cell. Read MoreFebruary 15, 2017 (YouTube)
Video of a T-cell attacking a cancer cell. Read MoreJune 4, 2018 (HealthDay News) Positive results seen for autologous infusions of expanded regulatory T lymphocytes in three patients MONDAY, June 4, 2018 (HealthDay News) — A new immunotherapy appears …
Immunotherapy Promising for Slowing Progression of ALS Read MoreMay 19, 2018 (Medical News Today) This study was published in the Journal of Experimental Medicine. It discovered that when cholesterol levels are decreased, cancer fighting immunotherapy is more effective. …
New Study Finds that Lowering Cholesterol Improves Immunotherapy Read MoreApril 11, 2018 (HealthDay News) One-year overall survival of 61 percent for gemcitabine and cisplatin plus ipilimumab Gemcitabine and cisplatin (GC) plus ipilimumab is associated with a 69 percent objective …
Combo of Chemo & Immunotherapy Determined Feasible in Metastatic Bladder Cancer Read MoreDr. Renier Brentjens, MD, PhD from the Memorial Sloan Kettering Cancer Center, discusses the goal of armored CAR T-cells. He talks about how the researchers add additional genets to the …
The Goal of Armored CAR T Cells Read MoreMarch 23, 2018 (Medical News Today) A biodegradable gel has been developed to stop the recurrence of cancer. Scientists at the Dana-Farber Cancer Institute in Boston, MA, created a gel …
Cancer: How a novel gel could halt its return Read MoreFebruary 19, 2018 (YouTube) Constantine Tam, MD, FRACP, FRCPA, of Peter MacCallum Cancer Centre, Melbourne, Australia. Speaking from the American Society of Hematology (ASH) 2017 Annual Meeting and Exposition in …
VIDEO: CAR T-cells for CLL Read MoreFebruary 15, 2018 (YouTube) Alexander E. Perl, MD, associate professor of medicine, University of Pennsylvania, discusses the impact of CAR T-cell therapy for patients with acute lymphoblastic leukemia (ALL).
VIDEO: The Impact of CAR T-Cell Therapy on ALL Read MorePublished on February 13, 2018 Sattva S. Neelapu, MD, discusses the safety and practical implications for axi-cel (KTE-C19) as part of the ZUMA-1 trial, as well as the future for …
Axi-Cel and Future of CAR T-Cell Therapy in Lymphoma Read MoreDiagnosed with lymphoma, Nick Howe was out of options before he tried CAR T-Cell therapy at Nebraska Medicine. Today, the Omaha firefighter is in remission and expecting his first baby. …
Omaha Firefighter Receives CAR T-Cell Therapy – Nebraska Medicine Read More